Bilirubin-induced neural impairment: A special focus on myelination, age-related windows of susceptibility and associated co-morbidities

Seminars in Fetal and Neonatal Medicine

Volumn 20, Issue 1, 2015, Pages 14-19

  Brites, Dora ^a   Fernandes, Adelaide ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

Bilirubin induced neurological dysfunction; Hypoxia; Kernicterus; Sensitive time window; Sepsis; White matter damage

Indexed keywords

BILIRUBIN;

ASTROCYTE; BILIRUBIN INDUCED NEUROLOGIC DYSFUNCTION; BRAIN DEVELOPMENT; CELL ACTIVATION; CELL DEATH; CELL MATURATION; COMORBIDITY; CYTOTOXICITY; HUMAN; HYPERBILIRUBINEMIA; HYPOXIA; KERNICTERUS; MICROGLIA; MYELINATION; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; OLIGODENDROGLIA; REVIEW; SEPSIS; WHITE MATTER; WHITE MATTER INJURY; ANOXIA; BLOOD; CHEMICALLY INDUCED; COMPLICATION; DISEASE PREDISPOSITION; LEUKOENCEPHALOPATHIES; NEONATAL HYPERBILIRUBINEMIA; NERVOUS SYSTEM DISEASES; NEWBORN; PREMATURITY;

ANOXIA; BILIRUBIN; COMORBIDITY; DISEASE SUSCEPTIBILITY; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; INFANT, PREMATURE; KERNICTERUS; LEUKOENCEPHALOPATHIES; NERVOUS SYSTEM DISEASES; SEPSIS;

EID: 84922931419     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2014.12.002     Document Type: Review

References (50)

1. Brites D. Bilirubin injury to neurons and glial cells: new players, novel targets, and newer insights. Semin Perinatol 2011, 35:114-120.
2. Brites D. The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation. Front Pharmacol 2012, 3:88.
3. Shapiro S.M. Chronic bilirubin encephalopathy: diagnosis and outcome. Semin Fetal Neonatal Med 2010, 15:157-163.
4. Bhutani V.K., Vilms R.J., Hamerman-Johnson L. Universal bilirubin screening for severe neonatal hyperbilirubinemia. JPerinatol 2010, 30(Suppl.):S6-S15.
5. Slusher T.M., Olusaniya B.O. Neonatal jaundice in low- and middle-income countries. Care of the jaundiced neonate 2012, 263-273. McGraw-Hill, New York. D.K. Stevenson, M.J. Maisels, J.F. Watchko (Eds.).
6. Ebbesen F., Bjerre J.V., Vandborg P.K. Relation between serum bilirubin levels ≥450 μmol/L and bilirubin encephalopathy; a Danish population-based study. Acta Paediatr 2012, 101:384-389.
7. Vandborg P.K., Hansen B.M., Greisen G., Jepsen M., Ebbesen F. Follow-up of neonates with total serum bilirubin levels ≥25 mg/dL: a Danish population-based study. Pediatrics 2012, 130:61-66.
8. Soorani-Lunsing I., Woltil H.A., Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain?. Pediatr Res 2001, 50:701-705.
9. Babu T.A., Bhat B.V., Joseph N.M. Neurobehavior of term neonates with neonatal hyperbilirubinemia. JPediatr Neurosci 2013, 8:11-14.
10. Jangaard K.A., Fell D.B., Dodds L., Allen A.C. Outcomes in a population of healthy term and near-term infants with serum bilirubin levels of > or= 325 micromol/L (> or= 19 mg/dL) who were born in Nova Scotia, Canada, between 1994 and 2000. Pediatrics 2008, 122:119-124.
11. Rubin R.A., Balow B., Fisch R.O. Neonatal serum bilirubin levels related to cognitive development at ages 4 through 7 years. JPediatr 1979, 94:601-604.
12. Hokkanen L., Launes J., Michelsson K. Adult neurobehavioral outcome of hyperbilirubinemia in full term neonates - a 30 year prospective follow-up study. PeerJ 2014, 2:e294.
13. Volpe J.J. Encephalopathy of prematurity includes neuronal abnormalities. Pediatrics 2005, 116:221-225.
14. Volpe J.J. Neonatal encephalopathy: an inadequate term for hypoxic-ischemic encephalopathy. Ann Neurol 2012, 72:156-166.
15. Brites D., Bhutani V.K. Pathways involving bilirubin and other brain-injuring agents. Cerebral palsy: science and clinical practice 2014, 131-150. Mac Keith Press, London. B. Dan, M. Mayston, N. Paneth, L. Rosenbloom (Eds.).
16. Meredith R.M., Dawitz J., Kramvis I. Sensitive time-windows for susceptibility in neurodevelopmental disorders. Trends Neurosci 2012, 35:335-344.
17. Bortolussi G., Baj G., Vodret S., Viviani G., Bittolo T., Muro A.F. Age-dependent pattern of cerebellar susceptibility to bilirubin neurotoxicity invivo in mice. Dis Model Mech 2014, 7:1057-1068.
18. Salmaso N., Jablonska B., Scafidi J., Vaccarino F.M., Gallo V. Neurobiology of premature brain injury. Nat Neurosci 2014, 17:341-346.
19. Dubois J., Dehaene-Lambertz G., Kulikova S., Poupon C., Huppi P.S., Hertz-Pannier L. The early development of brain white matter: a review of imaging studies in fetuses, newborns and infants. Neuroscience 2014, 276C:48-71.
20. Brites D., Fernandes A., Falcão A.S., Gordo A.C., Silva R.F., Brito M.A. Biological risks for neurological abnormalities associated with hyperbilirubinemia. JPerinatol 2009, 29(Suppl .1):S8-S13.
21. Fernandes A., Falcão A.S., Abranches E., Bekman E., Henrique D., Lanier L.M., et al. Bilirubin as a determinant for altered neurogenesis, neuritogenesis, and synaptogenesis. Dev Neurobiol 2009, 69:568-582.
22. Silva S.L., Vaz A.R., Diógenes M.J., van Rooijen N., Sebastião A.M., Fernandes A., et al. Neuritic growth impairment and cell death by unconjugated bilirubin is mediated by NO and glutamate, modulated by microglia, and prevented by glycoursodeoxycholic acid and interleukin-10. Neuropharmacology 2012, 62:2397-2407.
23. Amin S.B., Vogler-Elias D., Orlando M., Wang H. Auditory neural myelination is associated with early childhood language development in premature infants. Early Hum Dev 2014, 90:673-678.
24. Spencer-Smith M., Anderson P., Jacobs R., Coleman L., Long B., Anderson V. Does timing of brain lesion have an impact on children's attention?. Dev Neuropsychol 2011, 36:353-366.
25. Hansen T.W.R. Guidelines for treatment of neonatal jaundice. Is there a place for evidence-based medicine?. Acta Paediatr 2001, 90:239-241.
26. Hansen T.W.R., Maynard E.C., Cashore W.J., Oh W. Endotoxemia and brain bilirubin in the rat. Biol Neonate 1993, 63:171-176.
27. Petty M.A., Lo E.H. Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog Neurobiol 2002, 68:311-323.
28. Fernandes A., Silva R.F., Falcão A.S., Brito M.A., Brites D. Cytokine production, glutamate release and cell death in rat cultured astrocytes treated with unconjugated bilirubin and LPS. JNeuroimmunol 2004, 153:64-75.
29. Loron G., Olivier P., See H., Le Sache N., Angulo L., Biran V., et al. Ciprofloxacin prevents myelination delay in neonatal rats subjected to E.coli sepsis. Ann Neurol 2011, 69:341-351.
30. Favrais G., van de Looij Y., Fleiss B., Ramanantsoa N., Bonnin P., Stoltenburg-Didinger G., et al. Systemic inflammation disrupts the developmental program of white matter. Ann Neurol 2011, 70:550-565.
31. Graziani L.J., Mitchell D.G., Kornhauser M., Pidcock F.S., Merton D.A., Stanley C., et al. Neurodevelopment of preterm infants: neonatal neurosonographic and serum bilirubin studies. Pediatrics 1992, 89:229-234.
32. Kim M.H., Yoon J.J., Sher J., Brown A.K. Lack of predictive indices in kernicterus: a comparison of clinical and pathologic factors in infants with or without kernicterus. Pediatrics 1980, 66:852-858.
33. Mayor F., Pages M., Diez-Guerra J., Valdivieso F., Mayor F. Effect of postnatal anoxia on bilirubin levels in rat brain. Pediatr Res 1985, 19:231-236.
34. Alderliesten T., Nikkels P.G., Benders M.J., de Vries L.S., Groenendaal F. Antemortem cranial MRI compared with postmortem histopathologic examination of the brain in term infants with neonatal encephalopathy following perinatal asphyxia. Archs Dis Childh Fetal Neonatal Ed 2013, 98:F304-F309.
35. Vert P., Grojean S., Daval J.L. [Combined neuronal toxicity of bilirubin and hypoxia. Study of cultured rat neurons.]. Bull Acad Natl Med 2001, 185:1417-1426. discussion 1427-8.
36. Falcão A.S., Silva R.F., Fernandes A., Brito M.A., Brites D. Influence of hypoxia and ischemia preconditioning on bilirubin damage to astrocytes. Brain Res 2007, 1149:191-199.
37. Brito M.A., Zurolo E., Pereira P., Barroso C., Aronica E., Brites D. Cerebellar axon/myelin loss, angiogenic sprouting, and neuronal increase of vascular endothelial growth factor in a preterm infant with kernicterus. JChild Neurol 2012, 27:615-624.
38. Barateiro A., Fernandes A. Temporal oligodendrocyte lineage progression: invitro models of proliferation, differentiation and myelination. Biochim Biophys Acta 2014, 1843:1917-1929.
39. Rees S., Inder T. Fetal and neonatal origins of altered brain development. Early Hum Dev 2005, 81:753-761.
40. Back S.A., Rosenberg P.A. Pathophysiology of glia in perinatal white matter injury. Glia 2014, 62:1790-1815.
41. Brito M.A., Pereira P., Barroso C., Aronica E., Brites D. New autopsy findings in different brain regions of a preterm neonate with kernicterus: neurovascular alterations and up-regulation of efflux transporters. Pediatr Neurol 2013, 49:431-438.
42. Martich-Kriss V., Kollias S.S., Ball W.S. MR findings in kernicterus. Am J Neuroradiol 1995, 16:819-821.
43. Gkoltsiou K., Tzoufi M., Counsell S., Rutherford M., Cowan F. Serial brain MRI and ultrasound findings: relation to gestational age, bilirubin level, neonatal neurologic status and neurodevelopmental outcome in infants at risk of kernicterus. Early Hum Dev 2008, 84:829-838.
44. Lakovic K., Ai J., D'Abbondanza J., Tariq A., Sabri M., Alarfaj A.K., et al. Bilirubin and its oxidation products damage brain white matter. JCereb Blood Flow Metab 2014, 34:1837-1847.
45. Genc S., Genc K., Kumral A., Baskin H., Ozkan H. Bilirubin is cytotoxic to rat oligodendrocytes invitro. Brain Res 2003, 985:135-141.
46. Barateiro A., Vaz A.R., Silva S.L., Fernandes A., Brites D. ER stress, mitochondrial dysfunction and calpain/JNK activation are involved in oligodendrocyte precursor cell death by unconjugated bilirubin. Neuromolecular Med 2012, 14:285-302.
47. Barateiro A., Miron V.E., Santos S.D., Relvas J.B., Fernandes A., Ffrench-Constant C., et al. Unconjugated bilirubin restricts oligodendrocyte differentiation and axonal myelination. Mol Neurobiol 2013, 47:632-644.
48. Barateiro A., Domingues H.S., Fernandes A., Relvas J.B., Brites D. Rat cerebellar slice cultures exposed to bilirubin evidence reactive gliosis, excitotoxicity and impaired myelinogenesis that is prevented by AMPA and TNF-alpha inhibitors. Mol Neurobiol 2014, 49:424-439.
49. Barateiro A., Domingues H.S., Miron V.E., Tukey R.H., Santos S., Ffrench-Constant C., et al. Unconjugated bilirubin adversely affects myelinogenesis. JNeurochem 2013, 125:197.
50. Yuan T., Liao W., Feng N.H., Lou T.L., Niu X., Zhang A.J., et al. Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion. Stem Cell Res Ther 2013, 4:73.